Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold

americanpharmaceuticalreviewSeptember 07, 2020

Tag: Abbott , LIFE-BTK , BTK

PharmaSources Customer Service